Registry-listed formulations

This catalogue entry has no confirmed scientific concept.

Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.

0 source entries across 0 studies. This list may not include all unresolved or historical entries.

    Success Metrics

    Clinical Success Rate
    33.3%

    Based on 1 completed trials

    Completion Rate
    33%(1/3)
    Active Trials
    0(0%)
    Results Posted
    0%(0 trials)
    Terminated
    2(67%)

    Phase Distribution

    Not Applicable
    2
    67%
    Phase 2/3
    1
    33%

    Phase Distribution

    0

    Early Stage

    1

    Mid Stage

    0

    Late Stage

    Phase Distribution3 total trials
    Phase 2/3Combined phases
    1(33.3%)
    N/ANon-phased studies
    2(66.7%)

    Highest Phase Reached

    Phase 2/3

    Trial Status & Enrollment

    Completion Rate

    33.3%

    1 of 3 finished

    Non-Completion Rate

    66.7%

    2 ended early

    Currently Active

    0

    trials recruiting

    Total Trials

    3

    all time

    Status Distribution
    Completed(1)
    Terminated(2)

    Detailed Status

    Terminated2
    Completed1

    Development Timeline

    Analytics

    Development Status

    Total Trials
    3
    Active
    0
    Success Rate
    33.3%
    Most Advanced
    Phase 2/3

    Trials by Phase

    Phase 2/31 (33.3%)
    N/A2 (66.7%)

    Trials by Status

    terminated267%
    completed133%

    Recent Activity

    0 active trials
    Showing 3 of 3
    terminatedphase_2_3

    Testing the Efficacy of an Eye-tracking-based Treatment in Reducing Stress-related Symptoms in Veterans With PTSD

    NCT05243459
    completednot_applicable

    Increasing Psychological Resilience in Combat Soldiers Applying Advanced Eye-Tracking-Based Attention Bias Modification

    NCT05294848
    terminatednot_applicable

    Improving Performance of Combat Soldiers by Utilizing Attentional Training Based on Eye Tracking

    NCT05306197

    Clinical Trials (3)

    Showing 3 of 3 trials
    NCT05243459Phase 2/3

    Testing the Efficacy of an Eye-tracking-based Treatment in Reducing Stress-related Symptoms in Veterans With PTSD

    Terminated
    NCT05294848Not Applicable

    Increasing Psychological Resilience in Combat Soldiers Applying Advanced Eye-Tracking-Based Attention Bias Modification

    Completed
    NCT05306197Not Applicable

    Improving Performance of Combat Soldiers by Utilizing Attentional Training Based on Eye Tracking

    Terminated

    All 3 trials loaded

    Drug Details

    Intervention Type
    Behavioral
    Total Trials
    3